Prelude Therapeutics
PRLD
#9260
Rank
C$74.47 M
Marketcap
$1.35
Share price
0.57%
Change (1 day)
-69.42%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$2.93

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.04. In 2022 the company made an earnings per share (EPS) of -$3.41 a decrease over its 2021 EPS that were of -$3.39.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.93-14.3%
2022-$3.410.83%
2021-$3.39-61.3%
2020-$8.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.05 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA